Kenvue, the consumer health products business spun off from Johnson & Johnson in 2023, has appointed Bas Vorsteveld as its Area Managing Director for Northern Europe.
He will oversee Kenvue’s business in the UK, Ireland, Norway, Sweden, Denmark and Finland across a portfolio of brands including Nicorette, Aveeno, Johnson’s Baby, Listerine, Neutrogena, Calpol, OGX and Imodium.
Prior to joining Kenvue, Vorsteveld held the position of Vice President & General Manager for Great Britain and Ireland at Haleon. Over the past three years, he played a key role in driving growth in the business as it separated from GSK. Previously, he held several roles across Europe with GSK Consumer Healthcare, including VP & Head of Commercial Excellence EMEA and VP & General Manager France. Prior to that, he held GM roles at Novartis having started his career at Campina.
“We are excited to welcome Bas as Area Managing Director for Kenvue in Northern Europe and to our Europe, Middle East and Africa (EMEA) Leadership Team,” said Carlton Lawson, Group President, Europe, Middle East, Africa and Latin America at Kenvue.
“With almost three decades of experience in consumer goods and healthcare, Bas brings a proven track record of delivering industry-leading growth, building high-performing teams and deep industry knowledge that will be invaluable as we work to further boost Kenvue’s regional performance and growth. I’m confident that his experience advocating for the role our industry can and should play in promoting the value of self-care will help us deliver on our clear purpose to put the power of everyday care into the hands of more consumers”.
Vorsteveld added: “Kenvue’s iconic brands speak for themselves, and I am excited by the truly holistic approach to self-care we can offer through the entire range of different categories we thrive in. I’m thrilled to join the Northern Europe team, and I look forward to getting out across the region to spend time with our customers and stakeholders across the industry as well as our dedicated team.”
Last week, Kenvue posted mixed fourth-quarter results amid moves to boost its performance.
